Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nanoliposomal Irinotecan”

148 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 148 results

Post-approval studies (Phase 4)Not Yet RecruitingNCT06499610
What this trial is testing

Clinical Study of Irinotecan Liposome Combination Therapy for Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
First Affiliated Hospital Xi'an Jiaotong University 44
Testing effectiveness (Phase 2)UnknownNCT03986294
What this trial is testing

Second Line Treatment With Nal-IRI and S1 in Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 122
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07085273
What this trial is testing

Irinotecan Liposome II + 5-FU/LV + Oxaliplatin + Karelizumab in Neoadjuvant Treatment of Gastric Cancer

Who this might be right for
Gastric Cancer
The First Affiliated Hospital of Zhengzhou University 33
Testing effectiveness (Phase 2)Active Not RecruitingNCT06766019
What this trial is testing

Adebrelimab Combined With Irinotecan Liposomal (II), Oxaliplatin, and 5-FU/LV Conversion Therapy for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
The First Affiliated Hospital with Nanjing Medical University 47
Testing effectiveness (Phase 2)Looking for participantsNCT05927857
What this trial is testing

Ramucirumab (Cyramza), Nal-IRI (ONIVYDE) and Trifluridine/Tipiracil (Lonsurf) in Second Line Metastatic Gastric Cancer .

Who this might be right for
Metastatic Gastric AdenocarcinomaSecond LineChemotherapy
National Health Research Institutes, Taiwan 45
Testing effectiveness (Phase 2)Looking for participantsNCT06749691
What this trial is testing

Liposomal Irinotecan and Apatinib in ES-SCLC

Who this might be right for
Small Cell Lung Cancer Extensive Stage
Second Affiliated Hospital, School of Medicine, Zhejiang University 30
Testing effectiveness (Phase 2)Looking for participantsNCT07504471
What this trial is testing

Hepatic Arterial Infusion of Sodium Bicarbonate (NaHCO3) Combined With NASOX Regimen and Programmed Death-1 (PD-1) Inhibitors for Pancreatic Cancer Liver Metastases

Who this might be right for
Pancreatic NeoplasmsHepatic Metastasis of Pancreatic Cancer
Ruijin Hospital 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06332950
What this trial is testing

Safety and Efficacy of Adebrelimab Plus Irinotecan Liposome (II) With or Without Famitinib in ES-SCLC Pre-treated With Immunotherapy

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Baohui Han 80
Testing effectiveness (Phase 2)Looking for participantsNCT06467565
What this trial is testing

NALIRIFOX as Induction Therapy in LAPC

Who this might be right for
Pancreatic Ductal Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07591831
What this trial is testing

Liposomal Irinotecan Plus Enlonstobart for Platinum-Resistant Recurrent Ovarian Cancer

Who this might be right for
Platinum-resistant Recurrent Ovarian CancerFallopian Tube CancersEpithelial Ovarian Cancer+1 more
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07524374
What this trial is testing

SHR-1701 in Combination With Irinotecan Liposome (II) for Second-line Treatment of ESCC After Immunotherapy

Who this might be right for
ESCC
Zhigang Li 33
Large-scale testing (Phase 3)Study completedNCT04083235
What this trial is testing

Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment

Who this might be right for
Metastatic Adenocarcinoma of the Pancreas
Ipsen 770
Testing effectiveness (Phase 2)Study completedNCT03328884
What this trial is testing

Evaluation of the Efficacy and Safety of Nal-IRI for Progressing Brain Metastases in Breast Cancer Patients

Who this might be right for
Breast Cancer Metastatic
MedSIR 55
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06192680
What this trial is testing

Liposomal Irinotecan and Capecitabine Plus Bevacizumab as Second-line Therapy in Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Harbin Medical University 63
Not applicableNot Yet RecruitingNCT06462105
What this trial is testing

Liposomal Irinotecan Combination Regimen for First-line Treatment of Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Zhou Chengzhi 60
Large-scale testing (Phase 3)Study completedNCT03468335
What this trial is testing

2nd-line Therapy With Nal-IRI After Gem/Nab-pac in Advanced Pancreatic Cancer - Predictive Role of 1st-line Therapy

Who this might be right for
Locally Advanced Pancreatic CancerMetastatic Pancreatic Cancer
AIO-Studien-gGmbH 151
Testing effectiveness (Phase 2)Looking for participantsNCT07044921
What this trial is testing

Clinical Study of Irinotecan Liposome (II)-Based Combination Treatment for Irinotecan-resistant Colorectal Cancer.

Who this might be right for
Colorectal Cancer Metastatic
Chinese PLA General Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT06782685
What this trial is testing

Liposomal Irinotecan + Oxaliplatin + Bevacizumab Versus Liposomal Irinotecan + 5-FU/LV

Who this might be right for
Advanced Pancreatic Cancer (Part 1)
Dai, Guanghai 138
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07395063
What this trial is testing

A Clinical Study on the Treatment of Metastatic Colorectal Cancer at the Second-line or Beyond.

Who this might be right for
Metastatic Colorectal Cancer (CRC)
The Fourth Affiliated Hospital of Zhejiang University School of Medicine 68
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06513455
What this trial is testing

Irinotecan Liposome，Albumin Paclitaxel and Gemcitabine First-line Treatment for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Harbin Medical University 132
Load More Results